Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs.
about
Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysisAntiviral drug resistance as an adaptive processFactors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study.Impact of partial reimbursement on hepatitis B antiviral utilization and adherenceComparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients.Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis BTreatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B.Factors associated with poor adherence to antiviral treatment for hepatitis B.Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues.Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice.Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.Assessment of current criteria for primary nonresponse in chronic hepatitis B patients receiving entecavir therapy.Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B.INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
P2860
Q28074863-34E586AB-DB3E-4102-8102-E4F9DE0DF80EQ33878407-AC65B757-F144-408A-9868-3AB699937993Q34952020-B9067697-71D8-4094-BACA-4DAB1E890884Q35992395-676C70B3-47B3-4CB8-B216-1A928A6AB519Q36303221-2669C05A-1B3C-4E4D-99FC-E93795937F49Q36740003-6DD36BBE-25EE-443F-A248-ABFB3A743CB9Q36779207-4BB6A1B7-6719-4011-BFF1-78E99B786407Q38223361-818D6DAB-EF46-4C8E-BE22-16C966371157Q39018635-B42BEADF-F091-499C-8F16-554C1D3A4F2AQ40583804-2FE256DE-64D3-4837-9D82-BE7C12975207Q40630560-FA7E8A03-0C2A-4523-B45D-5AF90C1E286AQ41367567-D329C1DB-ED0F-4288-9D18-EE9495720408Q42223115-A27A564A-92B0-4F27-B2A6-C23C1569A825Q42259021-B1FA1C58-A96A-4E61-A256-CDDE628BF62DQ42280324-F255E2B4-4553-4340-8B7A-68E58D5156AAQ49974158-D1A73283-B13B-4BDE-ABCD-CF6CF3C39111Q54216584-8FF473F7-B3D7-438B-A81F-06F7A18CA6FFQ57069784-EB3D16A1-8D05-478A-B229-7BD5807C6784
P2860
Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Adherence to nucleos
@nl
Adherence to nucleos(t)ide ana ...... ith virological breakthroughs.
@en
type
label
Adherence to nucleos
@nl
Adherence to nucleos(t)ide ana ...... ith virological breakthroughs.
@en
prefLabel
Adherence to nucleos
@nl
Adherence to nucleos(t)ide ana ...... ith virological breakthroughs.
@en
P2093
P2860
P1476
Adherence to nucleos(t)ide ana ...... ith virological breakthroughs.
@en
P2093
C Hongthanakorn
K Oberhelman
R J Fontana
W Chotiyaputta
P2860
P304
P356
10.1111/J.1365-2893.2011.01494.X
P577
2011-07-14T00:00:00Z